 FRAMINGHAM, Mass., Jan. 05, 2021 GLOBE NEWSWIRE -- Arch Therapeutics, Inc. OTCQB: ARTH Arch or the Company, developer of novel self-assembling wound care and biosurgical devices, announced today that it will be presenting at the H.C. Wainwright BioConnect Conference, which will be held January 11-14, 2021. 